Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Pharvaris N.V. COM | 4,397,881 | 4,397,881 | 0 | 81,449 | 84,307 | 77.49% | +2,859 |
| Relay Therapeutics Inc.(RLAY) | 1,000,000 | 1,000,000 | 0 | 7,080 | 4,120 | 3.79% | -2,960 |
| Lyell Immunopharma, Inc. | 8,325,000 | 8,325,000 | 0 | 11,489 | 5,328 | 4.90% | -6,160 |
| Syndax Pharmaceuticals, Inc.(SNDX) | 875,000 | 0 | -875,000 | 16,844 | 0 | — | -16,844 |
| Kura Oncology, Inc.(KURA) | 1,849,947 | 1,726,882 | -123,065 | 36,148 | 15,041 | 13.83% | -21,107 |